The idea of curing a tumor with a fish therapy has been around for decades.
However, it is still not widely available.
In a new study, scientists from the University of Texas at Austin have shown that a single dose of the therapy can eradicate a cancer-causing protein from a cell.
They report their results in the journal Cell on March 8.
In the study, the scientists engineered cells to express a gene that can be used to destroy cancerous proteins.
This gene, which is part of a family of proteins called the sarcomas p38 proteins, is a critical component of normal cell growth and function.
However it can also cause a type of inflammation called fibrosis, which can lead to cancerous growths in other parts of the body.
In this study, they engineered cells in which the cancer-defective gene was deleted and engineered them to express it.
When the cells were injected into mice, they found that they could knock out the sarcolemmal protein p38 and stop the fibrosis.
They found that, in some cases, it was as effective as chemotherapy.
The researchers also found that treatment with this gene could be more effective than chemotherapy for other sarcoma-related proteins such as tumor necrosis factor-alpha (TNF-alpha), tumor necrotizing agent (TNA), and nuclear factor-κB (NF-κb), which play a role in the cancer cells’ self-renewal.
In addition, they also found a reduction in the level of tumor necrophages, the cells that are part of the immune system.
The study is important because cancer cells, like all other cells, have a genetic code that tells them how to divide.
This genetic code is called the germline, and it contains instructions for all of the genetic instructions that control the growth and division of cells.
But cancer cells don’t have this genetic code.
They also don’t know what instructions they are getting from their genetic code, so they can’t figure out what to do with it.
In other words, cancer cells have no idea what instructions to send to themselves to make them grow and multiply.
To find out how this genetic information might be misused, the researchers engineered cells so that they were genetically programmed to be able to divide and multiply according to a set of instructions.
They then injected the cells with this genetic programming.
They found that the treatment with the gene-directed therapy could effectively kill cancer cells in a dish.
The cells were harvested after 24 hours and then cultured to remove the cancerous cells.
The researchers found that these cells were killed by the treatment, and this was also true for cells treated with a cancer vaccine.
The team also found the treatment had no effect on normal cells, which were not affected by the therapy.
They believe that this study shows that a therapeutic gene is not only more effective for killing cancer cells than chemotherapy, but that it also can kill normal cells in the dish as well.
“We have shown for the first time that we can kill cells in vitro, and that the tumor cell death can be prevented with a therapeutic treatment,” says Daniel G. Pate, a professor of biological engineering at UT Austin and one of the study’s senior authors.
“This is a first step in identifying a therapy that can effectively treat cancer and its precursors, but more research is needed to find out what other cancers this gene can be targeted to.”###”The therapeutic gene can also prevent the growth of tumor cells,” Pate adds.
“It has also shown that it can kill cancerous tumors in mice.
This study is exciting because it shows that it has the potential to be a treatment for cancers and their precursers.”###The study was funded by the National Institutes of Health (grant R01CA027849).